Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Ryoko Yamasaki"'
Autor:
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Miyuki Sugimoto, Yuko Ishihara, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Masuzu Ueda, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3266-3277 (2019)
Abstract: The cost of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML) is a substantial economic burden. In Japan, imatinib, dasatinib, and nilotinib are now approved as first-line treatment of CML in chronic phase
Externí odkaz:
https://doaj.org/article/457d89f637d1478bad0cfb53f35c1dde
Autor:
Kiyomi Mashima, Iekuni Oh, Ken Fujiwara, Junko Izawa, Norihito Takayama, Hirofumi Nakano, Yasufumi Kawasaki, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Nobuhiko Ohno, Yoshinobu Kanda
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245232 (2021)
Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive drugs, such as anti-thymocyte globulin, alemtuzumab, and post-transplant cyclophosphamide, ha
Externí odkaz:
https://doaj.org/article/0aaa237dce9444c39147d32e9e85fd09
Autor:
Kana Sakamoto, Hideki Nakasone, Hidenori Wada, Ryoko Yamasaki, Yuko Ishihara, Koji Kawamura, Masahiro Ashizawa, Miki Sato, Kiriko Terasako-Saito, Tomohito Machishima, Shun-ichi Kimura, Misato Kikuchi, Shinichi Kako, Junya Kanda, Rie Yamazaki, Aki Tanihara, Junji Nishida, Yoshinobu Kanda
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73754 (2013)
BACKGROUND: Preemptive therapy with ganciclovir (GCV) based on the results of a cytomegalovirus (CMV) antigenemia assay is a standard strategy for preventing CMV disease after allogeneic hematopoietic cell transplantation (HCT). However, the appropri
Externí odkaz:
https://doaj.org/article/3f5bf9431cf0458585ab03a1d3d09fe0
Autor:
Takashi Nagayama, Shin-ichiro Fujiwara, Tomohiro Kikuchi, Kaoru Onda, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Sae Matsuoka, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Tetsuaki Ban, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine, Yoshinobu Kanda
Publikováno v:
Leukemia & Lymphoma. 63:1694-1700
The definition of sarcopenia assessed by computed tomography (CT) varies among different reports, and few studies have examined the effect of muscle mass loss on the prognosis of post-hematopoietic cell transplantation (HCT). We retrospectively evalu
Autor:
Hirotomo Nakashima, Shin-Ichiro Kawaguchi, Shin-ichiro Fujiwara, Iekuni Oh, Yumiko Toda, Hirofumi Nakano, Takashi Nagayama, Ken Ohmine, Kento Umino, Sae Matsuoka, Takashi Ikeda, Rui Murahashi, Ryoko Yamasaki, Yoshinobu Kanda, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Shoko Ito, Tetsuaki Ban, Daisuke Minakata, Kaoru Hatano
Publikováno v:
International Journal of Hematology. 114:79-84
High-dose methotrexate (MTX) is widely used for the treatment of hematological malignancies. Despite the application of routine supportive care measures, such as intensive fluid hydration and urine alkalinization, nephrotoxicity is still a problem. T
Autor:
Shoko Ito, Shin-Ichiro Kawaguchi, Takashi Nagayama, Takashi Ikeda, Shin-ichiro Fujiwara, Iekuni Oh, Kaoru Morita, Masahiro Ashizawa, Kiyomi Mashima, Ken Ohmine, Yumiko Toda, Hirofumi Nakano, Chihiro Yamamoto, Kazuya Sato, Kento Umino, Ryoko Yamasaki, Kaoru Hatano, Daisuke Minakata, Yoshinobu Kanda
Publikováno v:
Bone Marrow Transplant
Gastrointestinal acute graft-versus-host disease (aGVHD) is a life-threatening complication that requires urgent and appropriate treatment. An endoscopic examination is considered the gold-standard for the diagnosis of gastrointestinal aGVHD. However
Autor:
Shoko Ito, Shin-ichiro Fujiwara, Tomoaki Yoshizawa, Kaori Hayatsu, Kaoru Sekiguchi, Rui Murahashi, Hirotomo Nakashima, Sae Matsuoka, Takashi Ikeda, Yumiko Toda, Shinichiro Kawaguchi, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Yoshinobu Kanda
Publikováno v:
Internal medicine (Tokyo, Japan). 61(21)
Tumor lysis syndrome (TLS) is a metabolic disorder caused by massive tumor lysis. Hypouricemic agents are administered to prevent TLS-related hyperuricemia and renal failure. We experienced three cases of urine xanthine crystals during TLS in patient
Autor:
Takashi Ikeda, Kiyomi Mashima, Iekuni Oh, Yumiko Toda, Kazuo Muroi, Yasufumi Kawasaki, Takashi Nagayama, Hirofumi Nakano, Daisuke Minakata, Shin-Ichiro Kawaguchi, Kaoru Morita, Masahiro Ashizawa, Shin-Ichi Ochi, Shin-ichiro Fujiwara, Kaoru Hatano, Chihiro Yamamoto, Kazuya Sato, Yoshinobu Kanda, Shoko Ito, Kento Umino, Ryoko Yamasaki, Ken Ohmine
Publikováno v:
Transplant International. 33:1723-1731
The speed of neutrophil recovery following allogeneic hematopoietic cell transplantation (allo‐HCT) varies widely among patients. We retrospectively evaluated the slope of neutrophil recovery (N slope) in 120 patients who underwent a first unrelate
Autor:
Ken Fujiwara, Masahiro Ashizawa, Takashi Inagaki, Shin-ichiro Fujiwara, Kento Umino, Morio Azuma, Daisuke Minakata, Hirofumi Nakano, Takashi Ikeda, Nobuhiko Ohno, Iekuni Oh, Kazuo Muroi, Kiyomi Mashima, Chihiro Yamamoto, Kazuya Sato, Ryoko Yamasaki, Kaoru Morita, Yoshinobu Kanda, Ken Ohmine, Kaoru Hatano
Publikováno v:
Acta Histochemica et Cytochemica
Leukemias are refractory hematopoietic malignancies, for which the development of new therapeutic agents requires in vivo studies using tumor-bearing mouse models. Although several organs are commonly examined in such studies to evaluate the disease
Autor:
Masahiro Ashizawa, Daisuke Minakata, Ken Ohmine, Chihiro Yamamoto, Takashi Nagayama, Kazuya Sato, Shin-Ichi Ochi, Shin-Ichiro Kawaguchi, Kaoru Morita, Shin-ichiro Fujiwara, Ryoko Yamasaki, Shoko Ito, Iekuni Oh, Yoshinobu Kanda, Kazuo Muroi, Kento Umino, Yumiko Toda, Hirofumi Nakano, Takashi Ikeda, Kiyomi Mashima, Kaoru Hatano, Kana Matsumoto
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e92-e96
Background A treatment strategy is needed for hemodialysis-dependent patients with end-stage renal disease who have relapsed/refractory diffuse large B-cell lymphoma (DLBCL). We examined the feasibility of salvage chemotherapy followed by autologous